Clinical Trial: Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880743) titled 'Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction' on Oct. 12.

Brief Summary: The goal of this clinical trial is to learn whether taking oral tranexamic acid (TXA) for one week after anterior cruciate ligament (ACL) reconstruction improves recovery in adolescents and young adults aged 14 to 25 years. All participants receive standard intravenous TXA during surgery. The main questions it aims to answer are:

* Does oral TXA lower knee pain at 2 weeks after surgery?

* Does oral TXA reduce the amount of opioid pain medicine used in the first 2 weeks?

* Does oral TXA improve knee range of motion at 2 weeks?...